[1]去甲氧柔红霉素联合阿糖胞苷治疗儿童难治性急非淋白血病 [2]氟达拉滨联合阿糖胞苷及粒细胞集落刺激因子方案治疗儿童复发难治性急性白血病的疗效 [3]白血病相关免疫表型与难治性急性髓细胞白血病的关系 [4]CD19特异性嵌合抗原受体T细胞治疗难治/复发B细胞淋巴瘤、急性B淋巴细胞白血病和慢性B淋巴细胞白血病的临床研究 [5]CLAAG-IDA方案治疗难治/复发急性髓系白血病（AML）临床疗效和安全性-一项多中心、单臂、前瞻性临床研究 [6]CD5 CAR-T Therapy for Refractory/Relapsed CD5+ T-cell Acute Lymphoblastic Leukemia [7]CD19特异性嵌合抗原受体T细胞治疗难治/复发B细胞淋巴瘤、急性B淋巴细胞白血病和慢性B淋巴细胞白血病的临床研究 [8]Surgical treatment of refractory epilepsy after chemotherapy in two children with leukemia [9]Potent Anti-leukemia Activities of Chimeric Antigen Receptor-Modified T Cells against CD19 in Chinese Patients with Relapsed/Refractory Acute Lymphocytic Leukemia [10]CD19 targeted CAR-T therapy versus chemotherapy in re-induction treatment of refractory/relapsed acute lymphoblastic leukemia: results of a case-controlled study